Chemical/Pharmaceutical Engineering Scholarship 2026 for Vaccine Manufacturing Open
Africa CDC, in partnership with the African Vaccine Manufacturing Initiative (AVMI), has officially opened applications for the second cohort of its Industrial Fellowship Programme in Vaccine Manufacturing. The fellowship, set to run from July 2026 through September 2027, will place 14 selected graduates at active vaccine manufacturing sites in Egypt, Senegal, or South Africa — three countries at the centre of the continent’s push toward pharmaceutical self-sufficiency.
The programme arrives at a moment of strategic urgency. The Partnerships for African Vaccine Manufacturing (PAVM) framework has set a target of producing 60 per cent of routine vaccines on the continent by 2040. Meeting that ambition requires roughly 12,500 full-time employees across vaccine development and manufacturing — a fourfold increase from the current base of between 2,000 and 3,000 professionals, many of whom work in R&D roles not fully dedicated to vaccine production. The Africa CDC Industrial Fellowship Programme in Vaccine Manufacturing is designed to close precisely this gap: not with more classroom instruction, but with structured, hands-on industrial placement grounded in current Good Manufacturing Practices (cGMP).
What the Africa CDC Vaccine Manufacturing Fellowship Covers?
The fellowship is fully funded by Africa CDC. Selected fellows receive return flight tickets to their placement country, a stipend to cover daily living expenses, visa fee coverage, and documentation support for visa processing. The programme lasts one full year, during which participants work within operational vaccine manufacturing facilities — gaining exposure to drug substance production, fill-and-finish processes, quality assurance, and the broader regulatory environment that governs pharmaceutical manufacturing in Africa.
This is not a lecture-based fellowship. The Africa CDC and AVMI Industrial Fellowship Programme was built around competency frameworks developed specifically by Africa CDC to benchmark what the continent’s vaccine workforce actually needs. Fellows emerge with demonstrable industrial skills that make them immediately employable by vaccine manufacturing institutions — a critical distinction from traditional academic postgraduate programmes.
Eligibility for the Africa CDC Industrial Fellowship 2026
Applicants must be citizens of an African Union member state and must have graduated within the past three years with a Bachelor’s or Master’s degree in one of the following fields: Pharmacy and Pharmaceutical Sciences, Pharmaceutical Biotechnology, Chemistry and Biochemistry, Chemical Engineering, or Biomanufacturing and Vaccine Manufacturing. A valid passport is required, along with proficiency in English or French. Candidates must be available to relocate to one of the three host countries for the full duration of the fellowship.
The programme explicitly encourages applications from women and candidates of all backgrounds, regardless of gender, race, disability, religious belief, caste, or marital status.
Why This Vaccine Manufacturing Fellowship Matters?
Until recently, building biomanufacturing talent in Africa has depended almost entirely on training programmes hosted outside the continent — expensive, visa-constrained, and unsustainable at the scale PAVM demands. The shortage of in-continent industrial placements has meant that even well-qualified graduates lack the practical manufacturing experience employers require. The Africa CDC AVMI Industrial Fellowship Programme directly addresses this structural bottleneck by embedding fellows within African manufacturing operations rather than sending them abroad.
The first cohort, launched in 2025, established proof of concept. This second cohort signals institutional commitment to scaling the model. With only 14 places available and the full backing of Africa CDC’s Pharmaceutical, Health and Manufacturing (PHAHM) division, selection will be highly competitive. A joint review committee comprising Africa CDC, PHAHM, and AVMI representatives will evaluate all applications; only shortlisted candidates will be contacted.
Application Deadline and How to Apply
The deadline to apply for the Africa CDC Industrial Fellowship Programme in Vaccine Manufacturing (Cohort 2) is 30 April 2026. Selected candidates will be notified by 15 May 2026. Applications must be submitted through the official Africa CDC portal at: https://tools.africacdc.org/africacdcrc/surveys/?s=8AENFDHCDCCRHTD4
For graduates across the African Union with the right qualifications and a willingness to relocate, this fellowship represents one of the most direct pathways into the continent’s emerging vaccine manufacturing sector — a sector that, by design, is only going to grow.